Vickers Venture Partners is an international venture capital firm that focuses on early-stage and growth capital investments globally. Their core strategy involves investing in "deep tech" companies with proprietary technologies that aim to solve significant global challenges, while also integrating Environmental, Social, and Governance (ESG) considerations into their investment process.
33% of their portfolio is in Healthcare. Their most common stage is series-b (67% of deals). Average disclosed round size is $52.4M (across 5 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 AWAK Technologies | Series B | — | Sep 2023 |
 Aardvark Therapeutics, Inc. | Series B | $29M | Aug 2021 |
 Chooch.ai | Series A | $20M | Nov 2020 |
| AWAK Technologies | Growth | $40M | Dec 2019 |
 Eavor Technologies Inc. | Series B | $40M | — |
| RRWDC Industries | Series B | $133M | — |
Top Co-Investors
bp ventures1 shared
Chevron Technology Ventures1 shared
Temasek Holdings1 shared
BDC Capital1 shared
Streamlined Ventures1 shared
Alumni Ventures Group1 shared
Seeds Capital1 shared
Advanced MedTech1 shared
Last updated: 8 March 2026